Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Corporate Profile for Conceptus Inc., dated Nov. 14, 1997.


--(BUSINESS WIRE)--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0-

Published Date:   Nov. 14, 1997

Company Name:     Conceptus Inc.

Address:          1021 Howard Ave.
                  San Carlos, CA 94070

Main Telephone
 Number:          650/802-7240

Internet Home
 Page Address
  (URL)           www.conceptus.com

Chief Executive
 Officer:         Kathryn Tunstall

Chief Financial
 Officer:         Sanford Fitch

Investor Relations
 Contact:         Sanford Fitch
 Business number: 650/802-7289

Trading Symbol/
 Exchange:        CPTS

Industry:         Medical Devices

Market Makers:    Piper Jaffray, UBS, Josephthal





Company description:

Conceptus Inc Conceptus, which is headquartered in Mountain View, California, was founded in 1992. The company began development of micro-catheter and guidewire systems that allowed physicians to access and navigate the fallopian tubes using a non-incisional approach. . designs, develops and markets innovative interventional medical devices for use in reproductive medicine. The Company's initial focus is on the development of systems to improve the diagnosis and treatment of fallopian tube fallopian tube (fəlō`pēən), either of a pair of tubes extending from the uterus to the paired ovaries in the human female, also called oviducts, technically known as the uterine tube.  diseases and disorders, a primary cause of infertility infertility, inability to conceive or carry a child to delivery. The term is usually limited to situations where the couple has had intercourse regularly for one year without using birth control. . The Company is introducing a novel technology designed to improve the safety and ease-of-use of therapeutic hysteroscopy, a growing, less-invasive alternative to hysterectomy hysterectomy (hĭstərĕk`təmē), surgical removal of the uterus. A hysterectomy may involve removal of the uterus only or additional removal of the cervix (base of the uterus), fallopian tubes (salpingectomy), and ovaries . The Company is also developing a non-surgical approach to fallopian tube sterilization sterilization

Any surgical procedure intended to end fertility permanently (see contraception). Such operations remove or interrupt the anatomical pathways through which the cells involved in fertilization travel (see reproductive system).
, the most commonly performed contraceptive contraceptive /con·tra·cep·tive/ (-sep´tiv)
1. diminishing the likelihood of or preventing conception.

2. an agent that so acts.
 procedure worldwide.

CONTACT: Conceptus Inc.
COPYRIGHT 1997 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 14, 1997
Words:193
Previous Article:Corporate Profile for Indigita Corp., dated Nov. 14, 1997.
Next Article:Corporate Profile for Merrin Information Services, dated Nov. 14, 1997.
Topics:



Related Articles
Conceptus Reports Fourth Quarter and Year 1996 Financial Results.
Conceptus Announces Management Changes.
Conceptus Reports First Quarter 1997 Financial and Operational Results.
Conceptus Reports Third Quarter 1997 Financial and Operational Results.
Conceptus Reports Third Quarter 1999 Financial and Operational Results.
Conceptus Names Dr. Marie-Helene Plais-Cotrel to Board of Directors; Fills Board Seat Previously Held by Howard Palefsky.
Conceptus to Present at CIBC World Markets 12th Annual Health Care Conference.
Conceptus Receives Canadian Approval To Market Essure; Company Submits First Pre-Market Approval Module to the U.S. FDA.
FDA CLEARS NESS HANDMASTER FOR US STROKE-VICTIM MARKET.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles